AMA applauds congressional action on prescription drug transparency

| 1 Min Read

Statement attributable to:
Barbara McAneny, M.D.
President, American Medical Association

“The AMA believes in transparency in prescription drug pricing, and we are pleased the House Ways & Means Committee moved the issue forward. Patients and their physicians want to be armed with more information, yet the current situation is opaque if not impenetrable. The committee is rightfully determined to expose factors that lead to high drug prices, and we look forward to continuing our efforts in that regard.”

Full press statement available when you sign in

Sign in to the AMA website to get the full version of this press statement. 

AMA membership has its advantages

  • Be a part of the nation's largest physician organization
  • Play a role in shaping the future of health care
  • Enjoy exclusive perks and savings

Not a member? Become a member now.

 

FEATURED STORIES

Figures and large health care icons

Geisinger CMO works to cut friction and lift care

| 7 Min Read
Judge's gavel in movement with a virtual text

Don’t open door to more frivolous medical liability lawsuits

| 5 Min Read
Client at a spa appointment

36 states lack regulatory oversight of med spas

| 6 Min Read
Physician points at tablet

After the survey: Turning physician well-being results into change

| 15 Min Read